viewDaily Mail and General Trust

Daily Mail shares lower as Citi downgrades

“It’s been a tough year for DMGT.," said analyst Natasha Brilliant as she downgraded the newspaper group.

Daily mail
Citi's price target moves to 600p from 880p.

Daily Mail and General Trust Plc (LON: DMGT) shares were down 2.2% on Tuesday as Citigroup warned investors against trying to catch a falling knife and downgraded the share.

Citi analyst Natasha Brilliant moved the bank’s rating to neutral and lowered the price target to 600p from 880p.

READ: DMGT slumps as it warns of further declines in newspaper advertising after 2017 loss

“It’s been a tough year for DMGT. We saw two profit warnings in H1 under the new management team,” the analyst said.

“And at the FY17 results last week, expectations for next year were rebased which, coupled with a dilutive disposal of EDR, has resulted in a more than 20 percent cut to consensus earnings.”

Brilliant added: “The company themselves believe there is more work to be done on the portfolio, and a number of DMGT’s underlying markets remain challenged with both cyclical and structural headwinds taking effect.

READ: Daily Mail upgraded by Goldman Sachs to 'neutral' from 'sell' following underperformance

“At this stage, we have limited visibility on any potential improvement. On the positive, the balance sheet is in good shape suggesting a potential for increased shareholder returns, and valuation does not look stretched vs peers.”

The Citi analyst reckons the risk/reward is less compelling than it was before.

Quick facts: Daily Mail and General Trust

Price: 774 GBX

Market: LSE
Market Cap: £1.63 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Imaging Biometrics take on Professor Jay Urbain to accelerate their tumour...

IQ-AI Limited’s (LON:IQAI) subsidiary, Imaging Biometrics (IB) has enlisted the expertise of Jay Urbain, PhD to its software development team. Dr. Urbain, a data scientist speaks to Proactive's Katie Pilbeam about his experience in the sector and how enthusiastic he is about...

6 minutes ago

2 min read